Mucopolysaccharidosis Type I (MPS I) is a rare genetic lysosomal storage disease caused by a mutation of IDUA gene. IDUA codes for α-L-iduronidase (IDUA), a lysosomal hydrolase that degrades glycosaminoglycans (GAGs): heparan sulphate and dermatan sulphate. GAGs are structural and signalling molecules that have a crucial role in controlling a variety of cell functions and their interaction with the extracellular matrix. Because of GAG's widespread action in cellular metabolism, MPS I is a progressive and disabling multisystemic disorder. Nowadays, the therapies available allowed patients to reach the adult life and the consequences of the disease in their reproductive system are mostly unknown. We aimed to investigate whether IDUA disruptio...
Central oxytocin (OT) and arginine-vasopressin (AVP) have been shown to play an important role in se...
Constitutively activating mutations in luteinizing hormone receptor (LHCGR) cause a condition called...
<div><p>Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease cau...
Mucopolysaccharidosis (MPS) I is a lysosomal storage disorder (LSD) that is characterised by alpha-L...
Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natu...
Mucopolysaccharidosis (MPS) type IIIA or Sanfilippo syndrome is a lysosomal storage disorder charact...
With recent advances in molecular genetics, the popularity of mice as subjects for behavioral neuros...
Sexual behavior was observed in male mice that were homozygous for a null mutation of the c-fos prot...
Mucopolysaccharidosis type I (MPS I) is considered to represent the prototypical mucopolysaccharide ...
Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease caused by m...
Although neural substrates of mammalian female mating behavior have been described [1, 2], the assoc...
The cause of neurodegeneration in MPS mouse models is the focus of much debate and what the underlyi...
SummaryAlthough neural substrates of mammalian female mating behavior have been described [1, 2], th...
Mucopolysaccharidosis type I (MPS I) is an autosomal recessive genetic disorder resulting from defic...
Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natu...
Central oxytocin (OT) and arginine-vasopressin (AVP) have been shown to play an important role in se...
Constitutively activating mutations in luteinizing hormone receptor (LHCGR) cause a condition called...
<div><p>Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease cau...
Mucopolysaccharidosis (MPS) I is a lysosomal storage disorder (LSD) that is characterised by alpha-L...
Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natu...
Mucopolysaccharidosis (MPS) type IIIA or Sanfilippo syndrome is a lysosomal storage disorder charact...
With recent advances in molecular genetics, the popularity of mice as subjects for behavioral neuros...
Sexual behavior was observed in male mice that were homozygous for a null mutation of the c-fos prot...
Mucopolysaccharidosis type I (MPS I) is considered to represent the prototypical mucopolysaccharide ...
Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease caused by m...
Although neural substrates of mammalian female mating behavior have been described [1, 2], the assoc...
The cause of neurodegeneration in MPS mouse models is the focus of much debate and what the underlyi...
SummaryAlthough neural substrates of mammalian female mating behavior have been described [1, 2], th...
Mucopolysaccharidosis type I (MPS I) is an autosomal recessive genetic disorder resulting from defic...
Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natu...
Central oxytocin (OT) and arginine-vasopressin (AVP) have been shown to play an important role in se...
Constitutively activating mutations in luteinizing hormone receptor (LHCGR) cause a condition called...
<div><p>Severe mucopolysaccharidosis type II (MPS II) is a progressive lysosomal storage disease cau...